nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—CA12—Hydrochlorothiazide—nephrolithiasis	0.457	0.553	CbGbCtD
Zoledronate—CA2—Hydrochlorothiazide—nephrolithiasis	0.37	0.447	CbGbCtD
Zoledronate—CA2—collecting duct of renal tubule—nephrolithiasis	0.014	0.256	CbGeAlD
Zoledronate—Oral disorder—Hydrochlorothiazide—nephrolithiasis	0.00678	0.06	CcSEcCtD
Zoledronate—Shoulder pain—Hydrochlorothiazide—nephrolithiasis	0.00636	0.0563	CcSEcCtD
Zoledronate—GGPS1—nephron tubule—nephrolithiasis	0.00562	0.103	CbGeAlD
Zoledronate—GGPS1—renal system—nephrolithiasis	0.00511	0.0932	CbGeAlD
Zoledronate—GGPS1—kidney—nephrolithiasis	0.00494	0.0901	CbGeAlD
Zoledronate—GGPS1—cortex of kidney—nephrolithiasis	0.00481	0.0878	CbGeAlD
Zoledronate—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.00451	0.0399	CcSEcCtD
Zoledronate—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.0041	0.0363	CcSEcCtD
Zoledronate—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.00349	0.0309	CcSEcCtD
Zoledronate—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.00306	0.0271	CcSEcCtD
Zoledronate—Toothache—Hydrochlorothiazide—nephrolithiasis	0.00282	0.0249	CcSEcCtD
Zoledronate—FDPS—nephron tubule—nephrolithiasis	0.00259	0.0473	CbGeAlD
Zoledronate—CA12—renal system—nephrolithiasis	0.00238	0.0435	CbGeAlD
Zoledronate—FDPS—renal system—nephrolithiasis	0.00235	0.043	CbGeAlD
Zoledronate—CA12—kidney—nephrolithiasis	0.0023	0.042	CbGeAlD
Zoledronate—FDPS—kidney—nephrolithiasis	0.00228	0.0416	CbGeAlD
Zoledronate—FDPS—cortex of kidney—nephrolithiasis	0.00222	0.0405	CbGeAlD
Zoledronate—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00212	0.393	CbGpPWpGaD
Zoledronate—Numbness—Hydrochlorothiazide—nephrolithiasis	0.00207	0.0183	CcSEcCtD
Zoledronate—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00198	0.0175	CcSEcCtD
Zoledronate—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00191	0.0169	CcSEcCtD
Zoledronate—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0019	0.0168	CcSEcCtD
Zoledronate—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00179	0.0158	CcSEcCtD
Zoledronate—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00173	0.0153	CcSEcCtD
Zoledronate—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00168	0.0149	CcSEcCtD
Zoledronate—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0143	CcSEcCtD
Zoledronate—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00157	0.0139	CcSEcCtD
Zoledronate—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00144	0.0127	CcSEcCtD
Zoledronate—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0125	CcSEcCtD
Zoledronate—CA2—nephron tubule—nephrolithiasis	0.00134	0.0245	CbGeAlD
Zoledronate—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00131	0.0116	CcSEcCtD
Zoledronate—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00131	0.0116	CcSEcCtD
Zoledronate—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00131	0.0116	CcSEcCtD
Zoledronate—ABCC1—cortex of kidney—nephrolithiasis	0.00129	0.0235	CbGeAlD
Zoledronate—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00128	0.0113	CcSEcCtD
Zoledronate—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00124	0.011	CcSEcCtD
Zoledronate—CA2—renal system—nephrolithiasis	0.00122	0.0223	CbGeAlD
Zoledronate—CA2—kidney—nephrolithiasis	0.00118	0.0216	CbGeAlD
Zoledronate—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00117	0.0103	CcSEcCtD
Zoledronate—CA2—cortex of kidney—nephrolithiasis	0.00115	0.021	CbGeAlD
Zoledronate—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00114	0.0101	CcSEcCtD
Zoledronate—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00113	0.01	CcSEcCtD
Zoledronate—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00112	0.00991	CcSEcCtD
Zoledronate—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00974	CcSEcCtD
Zoledronate—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00971	CcSEcCtD
Zoledronate—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00958	CcSEcCtD
Zoledronate—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00951	CcSEcCtD
Zoledronate—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00951	CcSEcCtD
Zoledronate—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00101	0.0089	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000999	0.00884	CcSEcCtD
Zoledronate—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000993	0.00879	CcSEcCtD
Zoledronate—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.000978	0.00866	CcSEcCtD
Zoledronate—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.000942	0.00834	CcSEcCtD
Zoledronate—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000932	0.00825	CcSEcCtD
Zoledronate—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000932	0.00825	CcSEcCtD
Zoledronate—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000914	0.00809	CcSEcCtD
Zoledronate—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000894	0.00792	CcSEcCtD
Zoledronate—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000876	0.00775	CcSEcCtD
Zoledronate—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000856	0.00758	CcSEcCtD
Zoledronate—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000848	0.0075	CcSEcCtD
Zoledronate—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000799	0.00707	CcSEcCtD
Zoledronate—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000769	0.0068	CcSEcCtD
Zoledronate—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00076	0.00673	CcSEcCtD
Zoledronate—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000749	0.00663	CcSEcCtD
Zoledronate—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000733	0.00649	CcSEcCtD
Zoledronate—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000724	0.00641	CcSEcCtD
Zoledronate—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00072	0.00637	CcSEcCtD
Zoledronate—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000706	0.00625	CcSEcCtD
Zoledronate—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000702	0.00621	CcSEcCtD
Zoledronate—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000695	0.00615	CcSEcCtD
Zoledronate—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000692	0.00613	CcSEcCtD
Zoledronate—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000688	0.00609	CcSEcCtD
Zoledronate—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000684	0.00606	CcSEcCtD
Zoledronate—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000675	0.00598	CcSEcCtD
Zoledronate—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000673	0.00596	CcSEcCtD
Zoledronate—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000672	0.00595	CcSEcCtD
Zoledronate—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00067	0.00593	CcSEcCtD
Zoledronate—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000662	0.00586	CcSEcCtD
Zoledronate—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000658	0.00583	CcSEcCtD
Zoledronate—Cough—Hydrochlorothiazide—nephrolithiasis	0.000654	0.00578	CcSEcCtD
Zoledronate—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000638	0.00564	CcSEcCtD
Zoledronate—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000638	0.00564	CcSEcCtD
Zoledronate—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000638	0.00564	CcSEcCtD
Zoledronate—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000635	0.00562	CcSEcCtD
Zoledronate—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00063	0.00558	CcSEcCtD
Zoledronate—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000624	0.00552	CcSEcCtD
Zoledronate—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000616	0.00546	CcSEcCtD
Zoledronate—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000611	0.00541	CcSEcCtD
Zoledronate—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000611	0.00541	CcSEcCtD
Zoledronate—Shock—Hydrochlorothiazide—nephrolithiasis	0.000601	0.00532	CcSEcCtD
Zoledronate—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000598	0.0053	CcSEcCtD
Zoledronate—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000597	0.00528	CcSEcCtD
Zoledronate—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000591	0.00523	CcSEcCtD
Zoledronate—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000583	0.00516	CcSEcCtD
Zoledronate—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000571	0.00506	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000557	0.00493	CcSEcCtD
Zoledronate—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000553	0.00489	CcSEcCtD
Zoledronate—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000549	0.00486	CcSEcCtD
Zoledronate—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000545	0.00482	CcSEcCtD
Zoledronate—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000543	0.00481	CcSEcCtD
Zoledronate—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000538	0.00476	CcSEcCtD
Zoledronate—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000531	0.0047	CcSEcCtD
Zoledronate—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000527	0.00466	CcSEcCtD
Zoledronate—Pain—Hydrochlorothiazide—nephrolithiasis	0.000523	0.00463	CcSEcCtD
Zoledronate—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000523	0.00463	CcSEcCtD
Zoledronate—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000504	0.00446	CcSEcCtD
Zoledronate—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0005	0.00442	CcSEcCtD
Zoledronate—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000486	0.0043	CcSEcCtD
Zoledronate—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000483	0.00428	CcSEcCtD
Zoledronate—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000483	0.00428	CcSEcCtD
Zoledronate—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00045	0.00399	CcSEcCtD
Zoledronate—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000439	0.00388	CcSEcCtD
Zoledronate—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000432	0.00383	CcSEcCtD
Zoledronate—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000418	0.0037	CcSEcCtD
Zoledronate—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000404	0.00358	CcSEcCtD
Zoledronate—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000389	0.00344	CcSEcCtD
Zoledronate—Rash—Hydrochlorothiazide—nephrolithiasis	0.000385	0.00341	CcSEcCtD
Zoledronate—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000385	0.00341	CcSEcCtD
Zoledronate—Headache—Hydrochlorothiazide—nephrolithiasis	0.000383	0.00339	CcSEcCtD
Zoledronate—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000363	0.00321	CcSEcCtD
Zoledronate—GGPS1—Metabolism—GRHPR—nephrolithiasis	0.000201	0.0374	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AGXT—nephrolithiasis	0.000179	0.0333	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—SLC26A1—nephrolithiasis	0.000152	0.0283	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—APRT—nephrolithiasis	0.000152	0.0283	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AQP1—nephrolithiasis	0.000109	0.0202	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GRHPR—nephrolithiasis	9.81e-05	0.0183	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CHRM3—nephrolithiasis	9.81e-05	0.0183	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AGXT—nephrolithiasis	8.75e-05	0.0163	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	8.62e-05	0.016	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	8.62e-05	0.016	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GRHPR—nephrolithiasis	8.58e-05	0.016	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GRHPR—nephrolithiasis	8.27e-05	0.0154	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	7.69e-05	0.0143	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AGXT—nephrolithiasis	7.65e-05	0.0142	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SLC26A1—nephrolithiasis	7.44e-05	0.0138	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APRT—nephrolithiasis	7.44e-05	0.0138	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AGXT—nephrolithiasis	7.37e-05	0.0137	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	7.03e-05	0.0131	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	7.03e-05	0.0131	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APRT—nephrolithiasis	6.5e-05	0.0121	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SLC26A1—nephrolithiasis	6.5e-05	0.0121	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GRHPR—nephrolithiasis	6.32e-05	0.0118	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SLC26A1—nephrolithiasis	6.27e-05	0.0117	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APRT—nephrolithiasis	6.27e-05	0.0117	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AGXT—nephrolithiasis	5.64e-05	0.0105	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	5.33e-05	0.00991	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	5.33e-05	0.00991	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AQP1—nephrolithiasis	5.3e-05	0.00986	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	4.95e-05	0.00921	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	4.95e-05	0.00921	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC26A1—nephrolithiasis	4.79e-05	0.00891	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CHRM3—nephrolithiasis	4.79e-05	0.00891	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APRT—nephrolithiasis	4.79e-05	0.00891	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AQP1—nephrolithiasis	4.63e-05	0.00861	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AQP1—nephrolithiasis	4.47e-05	0.00831	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	4.42e-05	0.00821	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	4.42e-05	0.00821	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CHRM3—nephrolithiasis	4.19e-05	0.00779	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CHRM3—nephrolithiasis	4.04e-05	0.00751	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	3.53e-05	0.00656	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AQP1—nephrolithiasis	3.42e-05	0.00635	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CHRM3—nephrolithiasis	3.09e-05	0.00574	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GRHPR—nephrolithiasis	3.06e-05	0.00569	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC26A1—nephrolithiasis	2.77e-05	0.00515	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AGXT—nephrolithiasis	2.73e-05	0.00507	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ATP6V0A4—nephrolithiasis	2.47e-05	0.00459	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC26A1—nephrolithiasis	2.32e-05	0.00431	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APRT—nephrolithiasis	2.32e-05	0.00431	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AQP1—nephrolithiasis	1.65e-05	0.00307	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CHRM3—nephrolithiasis	1.5e-05	0.00278	CbGpPWpGaD
